Authors
Latest:
Executive Roundtable: Innovations in Global Pharma LabelingFive industry experts discuss labeling challenges and trends in modernization.
Latest:
2021 Preview: A 360-Degree Global Market ViewDonna L. LaVoie outlines the takeaways of a recent industry webinar discussing global trends on public and private markets, JPM virtual week, and more.
Latest:
CDMOs are Exploring Risk-Sharing for Resilient Growth in a BANI WorldKey industry trends and how the relationships between companies and CDMOs are evolving to better meet the challenges of a BANI world.
Latest:
The Healthcare System is Changing—So How Should We Respond?What pharma needs to do to keep up with the rise in value-based care.
Latest:
Cracking Down on Speaker ProgramsWith heightened government scrutiny on educational forums, biopharma manufacturers need a sound framework that demonstrates they are following best practices.
Latest:
EU Medical Device Supply Chains and Trade Agreements: The COVID-19 ResponseAndrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
Latest:
How Market Access Can Determine Commercial SuccessUsing market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
Latest:
How to Lead and Succeed in the Biosimilars SpaceKey traits needed by leaders looking to grow their organizations in the biosimilars market.
Latest:
Shedding Light on Global Pharmaceutical Supply ChainsIncrease in new treatments also brings increase in logistical challenges for pharma.
Latest:
Patients and Data Disrupt the Life Sciences IndustryDelivering better patient outcomes hinges on innovation and adaptability.
Latest:
A New Era in European Life Sciences InvestmentInvestments setting up sector for future success that could one day rival its US counterpart.
Latest:
How Medical Affairs Can Contribute to Successful Drug LaunchFaster launch planning leads to greater access.
Latest:
New Technologies Come with New Litigation RisksCybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
Latest:
Navigating the European Market for Medical CannabisThere is considerable variation in the regulatory approach to medical cannabis between European countries. Yet, despite the complexity, there are clear routes to market, reports Peter Kohut.
Latest:
The Global Vaccine R&D Pipeline and Delivery ImplicationsThe current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Latest:
Asembia 2025: The Cost of Care for PatientsSubject matter experts share the challenges that patients face in terms of medication affordability, along with the role that specialty pharmacies can play in helping to tackle these issues.
Latest:
How AI is Changing the Drug Development JourneyWhile no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.
Latest:
Navigating the EU’s Joint Clinical AssessmentPathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.
Latest:
The Role of AI in Helping Clinicians Diagnose PatientsThree ways artificial intelligence can drive the necessary engagement between patients and HCPs.
Latest:
The Emergence of the Chief Value Officer in HealthcareOutlining the implications of this c-suite trend for pharma.
Latest:
The Future of Safety and Adverse Event ProcessesAddressing the increased use of technology in safety compliance processes and greater patient involvement.
Latest:
How Biopharma Can Rev Up the Analytics Engine to Boost Patient ComplianceWhile patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.
Latest:
Partnerships Are Key to Niche Markets in BrazilForging effective partnerships with local companies is particularly important when entering Brazil’s pharma market. Sameer Kolhe reports.
Latest:
Has Pharma Given Up on Long-Term Adherence?Will the FDA ultimately step in and mandate a credible effort to eradicate the mindset that long-term adherence is not achievable?
Latest:
Why Pharma Must Invest in Key Account Management CapabilitiesThe emergence of organized customers demands investment in advanced solutions and next-generation key account management.
